The Lightning Process is a controversial treatment that is sometimes used for children with chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME), a disabling illness that means 1% of UK secondary school children miss a day a week or more of school. Describing itself as “a training course that focuses on the science behind how the brain and body interact”, The Lightning Process has been met with scepticism in the scientific community.
Researchers decided to test the robustness of this treatment so, despite activists trying to stop them, they ran its first ever trial – an RCT that looked at the effectiveness and cost-effectiveness in children with CFS/ME. The results are published in the Journal of Archives of Disease in Childhood.
A roundup accompanied this briefing.
Prof. Esther Crawley, Professor of Child Health, School of Social and Community Medicine, University of Bristol